Filter by: Subject

Filter by: Subject

Results Per Page:

Prostate cancer (5)
Angiogenesis (4)
Cancer (4)
Drug resistance (4)
Health sciences articles SDG-03 (4)
Lung cancer (4)
Therapeutic targets (4)
Treatment (4)
Artificial intelligence (AI) (3)
Cell cycle (3)
Cervical cancer (3)
Colorectal cancer (CRC) (3)
Coronavirus disease 2019 (COVID-19) (3)
COVID-19 pandemic (3)
Diagnosis (3)
Lopinavir/ritonavir (LPV/r) (3)
Metabolites (3)
Metastasis (3)
Non-AIDS defining cancers (NADCs) (3)
Obesity (3)
Sub-Saharan Africa (SSA) (3)
Aberrant splicing (2)
Acquired immune deficiency syndrome (AIDS) (2)
Adenocarcinoma (2)
Africa (2)
Antiretroviral therapy (ART) (2)
Bioinformatics (2)
Brazil (2)
Carcinogenesis (2)
Cell cycle regulation (2)
Competing endogenous RNAs (ceRNAs) (2)
Differential gene expression (2)
DNA damage response (DDR) (2)
Domain with no name (DWNN) (2)
Efavirenz (EFV) (2)
Epigenetic modifications (2)
Gastric cancer (2)
Green nanotechnology (2)
Highly active antiretroviral therapy (HAART) (2)
Immunosuppression (2)
India (2)
Ingenuity pathway analysis (IPA) (2)
Machine learning (2)
Microbiome (2)
Microbiota (2)
MicroRNA (miRNA) (2)
MicroRNAs (miRNAs) (2)
Neurogenesis (2)
Next-generation sequencing (NGS) (2)
Oesophageal cancer (2)
p53 (2)
Papillary thyroid carcinoma (PTC) (2)
Patients (2)
Phytomedicine (2)
Prognosis (2)
Prostate cancer (PCa) (2)
Retinoblastoma binding protein 6 (RBBP6) (2)
Ribonucleic acid (RNA) (2)
South Africa (2)
Splice variants (2)
SR proteins (2)
Tanzania (2)
Venous thromboembolism (VTE) (2)
2,2 Diphenyl-1-picryl hydrazyl (DPPH) (1)
A549 cells (1)
Aberrant splicing events (1)
Absorption, distribution, metabolism, and excretion (ADME) (1)
Acute myeloid leukaemia (AML) (1)
Acute myeloid leukemia (AML) (1)
Adipose tissue (1)
Adrenomedullin (1)
African norms (1)
African population (1)
AIDS defining cancers (ADCs) (1)
AIDS-defining cancers (ADCs) (1)
AIDS-KS patients (1)
Alcohol consumption (1)
Alternate splicing (1)
Alternative mRNA splicing (AS) (1)
Alternative splicing (AS) (1)
Alzheimer’s disease (1)
Amyloid-beta (1)
Anastrozole (1)
Androgen receptor (AR) (1)
Anemia (1)
Angiotensin-aldosterone system (1)
Anti-cancer (1)
Anticancer (1)
Anticancer activity (1)
Anticoagulation practice (1)
Anticoagulation therapy (1)
Antimicrobial (1)
Antioxidant (1)
Antiretroviral (ARV) (1)
Apoptosis (1)
Arterial thrombosis (1)
AS events (1)
Asbestos (1)
Asbestos-induced GC (1)
Atrial fibrillation (AF) (1)